Researchers at Universit- Laval have developed a blue light to help bleary eyed shift workers regulate their internal clocks and get the sleep they need when they need it.
Author: The Medical News
Cataract surgery reduces rate of fractures in older patients with vision loss
A major study of Medicare beneficiaries shows that the risk of hip fractures was significantly reduced in patients who had had cataract surgery, compared to patients who did not undergo the procedure. Published in the August edition of the Journal of t…
Scientists identify new gene responsible for genetic form of blindness in newborns
One of the mysteries of blindness has been solved. A team of international scientists in collaboration with the Research Institute of the McGill University Health Centre (RI MUHC) identified a new gene responsible for Leber Congenital Amaurosis (LCA), …
New compound effective at blocking damage to the retina in diabetic retinopathy
Researchers at the University of Michigan Kellogg Eye Center have identified a compound that could interrupt the chain of events that cause damage to the retina in diabetic retinopathy. The finding is significant because it could lead to a novel therap…
Scientists discover new way to combat post-surgical scarring for glaucoma patients
Scientists at the Singapore Eye Research Institute (SERI) and Nanyang Technological University (NTU) have developed an innovative way to combat post-surgical scarring for glaucoma patients.
Researchers isolate elusive human gene that causes NMNAT1-related Leber congenital amaurosis
Researchers from the Massachusetts Eye and Ear Infirmary, The Children’s Hospital of Philadelphia, Loyola University Chicago Health Sciences Division and their collaborators have isolated an elusive human gene that causes a common form of Leber congeni…
Long-term use of reverse geometry lenses may induce inflammatory response
Continuous long-term overnight use of reverse geometry lenses results in a significantly increased presence of inflammatory mediators compared with wearing 30-night silicone-hydrogel contact lenses or wearing no lenses, show study results.
FDA DODAC recommends approval of ThromboGenics’ ocriplasmin for VMA
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant …
AAQ chemical temporarily restores vision in blind mice
A team of University of California, Berkeley, scientists in collaboration with researchers at the University of Munich and University of Washington in Seattle has discovered a chemical that temporarily restores some vision to blind mice, and is working…
Early-age cataract surgery increases central corneal thickness
When congenital cataract surgery is performed at an early age, central corneal thickness increases, show study results published in the British Journal of Ophthalmology.
Regeneron reports total revenues of $304 million for second quarter 2012
Regeneron Pharmaceuticals, Inc. today announced financial and operating results for the second quarter of 2012 and provided an update on development programs.
Microneedles can deliver drug formulations into the eye
Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses – and …
Tiny microneedles to treat macular degeneration
Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses – and …
Foundation Fighting Blindness grants US$125,000 to Oxford BioMedica for UshStat Phase I/IIa trial
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US non-profit organisation, the Foundation Fighting Blindness (FFB), has granted an award of US$125,000 to the Company via its translational research arm, …
RPB awards $110,000 grant to Mass. Eye and Ear and HMS for research into blinding diseases
Research to Prevent Blindness (RPB) has awarded a grant of $110,000 to the Massachusetts Eye and Ear Infirmary to support research into the causes, treatment and prevention of blinding diseases. The research will be directed by Joan W. Miller, M.D., Ch…
Risk factors defined for retinal detachment after cataract surgery
Study results spanning 22 years show that the risk for retinal detachment after undergoing phacoemulsification for cataracts has fallen dramatically, but that younger, and male patients are more at risk for this adverse outcome than their older, female…
Otsuka, Acucela commence rebamipide ophthalmic suspension Phase 3 trial in dry eye syndrome
Acucela Inc., a clinical stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced the initiation of a Phase 3 clinical trial to evaluate rebamipide ophthalmic suspe…
U.S. News & World Report names U-M among 2012 America’s Best Hospitals
The University of Michigan Hospitals and Health Centers offer the best care in Michigan and some of the nation’s best care, according to a new ranking from U.S. News & World Report.
Glaucoma monitoring important in corneal dystrophy
The prevalence of glaucoma and/or ocular hypertension is more frequent in individuals with severe Fuchs’ endothelial corneal dystrophy than those without the condition, suggesting the importance of glaucoma screening in such patients, suggest US rese…
U.S. News & World Report names UCLA Medical Center among 2012 America’s Best Hospitals
Ronald Reagan UCLA Medical Center ranks among the top five American hospitals, according to a U.S. News & World Report survey that reviewed patient-outcomes data, reputation among physicians and other care-related factors.